Adding lanreotide to everolimus significantly prolonged progression-free survival compared with everolimus alone in patients ...
Effect of marital status and race on survival of patients with well differentiated neuroendocrine tumors (NETs). Clinicopathological factors related to survival in gastroenteropancreatic ...
Clinicopathological factors related to survival in gastroenteropancreatic neuroendocrine tumors (GEP-NET): 20 years experience in the American British Cowdray Medical Center. This is an ASCO Meeting ...
After 20 years of building radioisotope expertise as a manufacturer and supplier, German firm ITM Isotope Technologies is ...
WTEN Albany on MSN3d
‘Every week is a gift:’ Why Saratoga cancer survivor holds hopeWorld Cancer Day recognizes the millions of people affected by cancer each and every day. One cancer survivor in Saratoga ...
Lantheus, a Massachusetts-based developer of radiopharmaceuticals, has agreed to acquire the radiopharma contract development and manufacturing organization (CDMO) Evergreen Theragnostics. Lantheus ...
M: Metastasis; N: Node; T: Tumor. Data from [21]. Neuroendocrine tumors have demonstrated an increase in incidence and prevalence over the past decades, partly due to increased awareness ...
Dr. Jonathan R. Strosberg, discussed results of the CABINET trial evaluating Cabometyx versus placebo in advanced ...
The first patient has been dosed in a phase 1 dose-finding clinical trial evaluating iadademstat with Vidaza in patients with ...
Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of ...
DINNER: Enjoy a delicious meal and great entertainment at Cabell Midland High School’s Collegium musicum’s annual Valentine’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback